In settlement, Mylan doesn’t admit guilt for misclassifying life-saving device.
Source: For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million | Ars Technica
In settlement, Mylan doesn’t admit guilt for misclassifying life-saving device.
Source: For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million | Ars Technica